1.09

3.54% -0.04

After Hours: 1.08 -0.01 -0.92%

Alaunos Therapeutics Inc (TCRT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Alaunos Therapeutics Inc stock is traded at $1.09, with a volume of 79,146. It is down -3.54% in the last 24 hours and down -39.11% over the past month. Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Previous Close:

$1.13

Open:

$1.13

24h Volume:

79,146

Relative Volume:

0.11

Market Cap:

$2.77M

Revenue:

$3,000

Net Income/Loss:

$-4.11M

P/E Ratio:

-0.5026

EPS:

-2.1688

Net Cash Flow:

$-3.23M

1W Performance:

-9.17%

1M Performance:

-39.11%

6M Performance:

-63.79%

1Y Performance:

-56.40%

1-Day Range:

$1.08

$1.13

1-Week Range:

$1.08

$1.35

52-Week Range:

$1.02

$4.59

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name

Alaunos Therapeutics Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

(346) 355-4099

Address

501 E LAS OLAS BLVD, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2026-11-13

Latest SEC Filings

TCRT's Discussions on Twitter

Compare TCRT vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TCRT Alaunos Therapeutics Inc	1.09	2.77M	3,000	-4.11M	-3.23M	-2.1688
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-04-22	Resumed	Wells Fargo	Overweight

Alaunos Therapeutics Inc Stock (TCRT) Latest News

Sep 24, 2026

Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - kalkine.ca

Sep 24, 2026

Sep 22, 2026

Alaunos Therapeutics Announces New Registered Direct Offering - tipranks.com

Sep 22, 2026

Alaunos Therapeutics Enters Securities Purchase Agreement With Accredited Investors - TradingView

Sep 22, 2026

Sep 18, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com

Sep 18, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Sep 18, 2026

Alaunos Therapeutics prices registered direct offering to raise ~$1.12 million - TradingView

Sep 18, 2026

Alaunos Therapeutics raises $1.12M in registered direct offering By Investing.com - Investing.com Canada

Sep 18, 2026

Alaunos Therapeutics raises $1.12M in registered direct offering - Investing.com

Sep 18, 2026

Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules - manilatimes.net

Sep 18, 2026

Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 18, 2026

Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On - Benzinga

Sep 18, 2026

Sep 17, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Sep 17, 2026

Alaunos Therapeutics Updates Bylaws to Ease Shareholder Quorum - TipRanks

Sep 17, 2026

Sep 16, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Sep 16, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Sep 16, 2026

Sep 10, 2026

Alaunos Therapeutics (TCRT) Holds Firm at $1.56 as Buyers Defend the Lower RangeMoving Average Crossovers - siam.in

Sep 10, 2026

Sep 09, 2026

Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportMcClellan Oscillator - siam.in

Sep 09, 2026

Aug 23, 2026

Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayCall Resistance - vinanet.vn

Aug 23, 2026

Aug 20, 2026

Alaunos Therapeutics Reports Encouraging Early Obesity Drug Results - Stocktwits

Aug 20, 2026

Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest SessionAnnual Report - vinanet.vn

Aug 20, 2026

Aug 19, 2026

Alaunos (TCRT) EPS and Revenue: EPS Does Not Reach the Reported Estimate; Price Reaction: The Session Ends Near the Prior LevelAnalyst Coverage Count - vinanet.vn

Aug 19, 2026

Aug 14, 2026

Ziopharm: Q2 Earnings Snapshot - KTVB

Aug 14, 2026

Alaunos Therapeutics, Inc. Q2 2026: Revenue $0K, Net loss $988K, EPS $(0.41) — 10-Q Summary - TradingView

Aug 14, 2026

Alaunos Therapeutics (TCRT) warns on cash runway, Nasdaq compliance and losses - Stock Titan

Aug 14, 2026

Aug 11, 2026

Alaunos Therapeutics (TCRT) CEO granted 4,363 shares in lieu of cash salary - Stock Titan

Aug 11, 2026

Aug 08, 2026

Alaunos Therapeutics (TCRT) Holds Flat at $1.99 as Key Support and Resistance Levels Come into FocusTWAP Entry - dars.gov.et

Aug 08, 2026

Aug 06, 2026

Enterprise value to EBITDA forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView

Aug 06, 2026

Jul 31, 2026